Exane Derivatives’s Blue Bird Corp BLBD Stock Holding History

Exane Derivatives’s Portfolio BLBD Stock Details BLBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,139	Closed	-$21.4K	–	810
2022 Q1	$21.4K	Sell	1,139 -552	-33%	-$10.1K	0.01%	658
2021 Q4	$26.5K	Hold	1,691	–	–	0.01%	561
2021 Q3	$35.3K	Hold	1,691	–	–	0.01%	651
2021 Q2	$39.6K	Buy	+1,691	New	+$44.5K	0.01%	661
2021 Q1	–	Sell	-1,691	Closed	-$30.9K	–	926
2020 Q4	$30.9K	Hold	1,691	–	–	0.01%	496
2020 Q3	$20.6K	Hold	1,691	–	–	0.01%	439
2020 Q2	$25.4K	Sell	1,691 -395	-19%	-$4.95K	0.01%	389
2020 Q1	$22.8K	Hold	2,086	–	–	0.01%	403
2019 Q4	$46.5K	Sell	2,086 -976	-32%	-$19.5K	0.01%	359
2019 Q3	$58.3K	Hold	3,062	–	–	0.01%	362
2019 Q2	$60.3K	Buy	+3,062	New	+$56.1K	0.01%	375
2019 Q1	–	Sell	-12,802	Closed	-$233K	–	678
2018 Q4	$233K	Sell	12,802 -19,010	-60%	-$370K	0.04%	230
2018 Q3	$774K	Sell	31,812 -3,226	-9%	-$74.2K	0.15%	130
2018 Q2	$776K	Sell	35,038 -3,102	-8%	-$68K	0.13%	141
2018 Q1	$892K	Sell	38,140 -619	-2%	-$13.6K	0.18%	127
2017 Q4	$771K	Buy	+38,759	New	+$767K	0.13%	130

Other funds holding BLBD

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Exane Derivatives's BLBD Position: Q2 2022 in Review

Exane Derivatives sold out of Blue Bird Corp (BLBD) in Q2 2022, closing a stake of 1,139 shares — an estimated $21.4K sold.

Exane Derivatives first reported a position in BLBD in Q4 2017 and held it in 16 quarters. The position peaked at $892K in Q1 2018. 75 funds tracked by Wall St. Rank hold BLBD as of Q2 2022.

Exane Derivatives reported no remaining Blue Bird Corp position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,139 Blue Bird Corp shares in Q2 2022, an estimated $21.4K.
Exane Derivatives first reported a position in Blue Bird Corp in Q4 2017 and held it in 16 quarters.
Exane Derivatives's Blue Bird Corp position peaked at $892K in Q1 2018.
75 funds tracked by Wall St. Rank held Blue Bird Corp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.